Location
Australia, Oceania
Cheque size
$500K - $2M
Investment Stage
Pre Seed
Seed
Focus Areas
BioTech
About Investor
Dr. Jason Whitfield is an Investment Associate at Main Sequence, based in Sydney, Australia. He focuses on BioTech startups at the Pre-Seed and Seed stages, helping identify promising science-based innovations. Main Sequence typically invests between $500K and $2M for companies within his investment scope, with an average check size of around $1M. He supports the firm's evaluation and development of research-driven healthcare and biotechnology ventures. Overall, he is a valuable contact for founders building early-stage biotech companies.
Similar Investors
JF
Julie Fedele
Australia, Oceania
$5K - $5M
Pre Seed
,Seed
,MM
Melissa McBurnie
Australia, Oceania
$100K - $5M
Pre Seed
,Seed
,GM
Grant McCarthy
Australia, Oceania
$250K - $2.5M
Seed
,Series A
,DF
Dan Fitzgerald
Australia, Oceania
$250K - $5M
Seed
,NC
Nick Crocker
Australia, Oceania
$25K - $5M
Pre Seed
,Seed
,BB
Bill Bartee
Australia, Oceania
$250K - $20M
Seed
,Series A
,Is this Your Profile?
If you have any updates, please fill out our form.